![George Elston](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
George Elston
Director of Finance/CFO at
EYEPOINT, INC.
Net worth: 2 M $ as of 2026-05-30
Profile
George O.
Elston was the founder of Chatham Street Partners, founded in 2010, where the title held was Managing Partner.
Current jobs include Independent Trustee at DBX ETF Trust since 2010 and Chief Financial Officer & Executive Vice President at EyePoint, Inc. since 2023.
Former jobs include President & Chief Executive Officer at Enzyvant, Inc. from 2018 to 2019; President & Chief Executive Officer at Oncology Venture US, Inc. from 2017 to 2018; Director at AVANT Immunotherapeutics, Inc. in 2008; Director at Celldex Therapeutics, Inc. (Old) from 2004 to 2008; Independent Director at Celldex Therapeutics, Inc. from 2008 to 2017; Director at Celldex Research Corp.; Principal at C.
R.
Bard, Inc. (New Jersey); Chief Financial Officer, Secretary & Treasurer at Catalent JNP, Inc. from 2015 to 2016; Vice President-Finance at Elusys Therapeutics, Inc. from 2000 to 2009; Chief Financial Officer & Senior Vice President at KBI Biopharma, Inc. from 2013 to 2014; Chief Operating & Financial Officer at Optherion, Inc. from 2008 to 2010; Chief Financial Officer at Trillium USA, Inc.; Principal at Pricewaterhousecoopers LLC; and Chief Financial Officer at Enzyvant Therapeutics, Inc. from 2018 to 2019.
Education includes undergraduate studies at Pace University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
EYEPOINT, INC. 0.15% | 2026-05-24 | 121,691 ( 0.15% ) | 2 M $ | 2026-05-30 |
George Elston active positions
| Companies | Position | Start |
|---|---|---|
| EYEPOINT, INC. | Director of Finance/CFO | 2019-11-13 |
DBX ETF Trust
 DBX ETF Trust Investment Trusts/Mutual FundsMiscellaneous Exchange Traded Fund | Director/Board Member | 2010-09-30 |
Former positions of George Elston
| Companies | Position | End |
|---|---|---|
Enzyvant Therapeutics, Inc.
 Enzyvant Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics for treatment of rare diseases | Director of Finance/CFO | 2019-08-31 |
Enzyvant, Inc.
 Enzyvant, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Chief Executive Officer | 2019-08-31 |
Oncology Venture US, Inc.
 Oncology Venture US, Inc. Miscellaneous Commercial ServicesCommercial Services Develops therapies for cancer treatment | Chief Executive Officer | 2018-09-30 |
| CELLDEX THERAPEUTICS, INC. | Director/Board Member | 2017-06-14 |
| JUNIPER PHARMACEUTICALS INC | Director of Finance/CFO | 2016-12-30 |
Training of George Elston
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
48
1st degree connections
18
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 18 |
|---|---|
C. R. Bard, Inc. (New Jersey)
 C. R. Bard, Inc. (New Jersey) Medical SpecialtiesHealth Technology Designs, manufactures, packages, distributes and sells medical, surgical, diagnostic & patient care devices | Health Technology |
Catalent JNP, Inc.
 Catalent JNP, Inc. Miscellaneous Commercial ServicesCommercial Services Specializes in research and development of drugs & therapeutics | Commercial Services |
AVANT Immunotherapeutics, Inc.
 AVANT Immunotherapeutics, Inc. Medical SpecialtiesHealth Technology Discovers, develops and commercializes vaccines and therapeutics | Health Technology |
Celldex Therapeutics, Inc. (Old)
 Celldex Therapeutics, Inc. (Old) BiotechnologyHealth Technology Discovers, develops and commercializes novel immunotherapeutics | Health Technology |
Elusys Therapeutics, Inc.
 Elusys Therapeutics, Inc. BiotechnologyHealth Technology Develops immune-stimulatory and immune-derived therapies for the treatment of infectious diseases | Health Technology |
KBI Biopharma, Inc.
 KBI Biopharma, Inc. Miscellaneous Commercial ServicesCommercial Services Provides drug development and contract manufacturing services | Commercial Services |
Optherion, Inc.
 Optherion, Inc. Medical SpecialtiesHealth Technology Develops therapeutic products | Health Technology |
DBX ETF Trust
DBX ETF Trust Investment Trusts/Mutual FundsMiscellaneous Exchange Traded Fund | Miscellaneous |
EyePoint Pharmaceuticals, Inc.
 EyePoint Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets ophthalmic pharmaceuticals | Health Technology |
Pace University
 Pace University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Celldex Therapeutics, Inc.
 Celldex Therapeutics, Inc. BiotechnologyHealth Technology Develops and commercializes immunotherapy technologies for the treatment of cancer and other diseases | Health Technology |
Trillium USA, Inc.
 Trillium USA, Inc. Gas DistributorsUtilities Provides natural gas fueling services | Utilities |
Celldex Research Corp.
 Celldex Research Corp. Miscellaneous Commercial ServicesCommercial Services Engages in provision of biological research and development | Commercial Services |
Pricewaterhousecoopers LLC | |
Chatham Street Partners | |
Oncology Venture US, Inc.
Oncology Venture US, Inc. Miscellaneous Commercial ServicesCommercial Services Develops therapies for cancer treatment | Commercial Services |
Enzyvant, Inc.
Enzyvant, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
Enzyvant Therapeutics, Inc.
Enzyvant Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics for treatment of rare diseases | Health Technology |
- Stock Market
- Insiders
- George Elston
